|
1
|
WHO CVD Risk Chart Working Group. World
Health Organization cardiovascular disease risk charts: Revised
models to estimate risk in 21 global regions. Lancet Glob Health.
7:e1332–e1345. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Knuuti J, Wijns W, Saraste A, Capodanno D,
Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C,
Cuisset T, et al: 2019 ESC guidelines for the diagnosis and
management of chronic coronary syndromes. Eur Heart J. 41:407–477.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Collet JP, Thiele H, Barbato E, Barthélémy
O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T,
Folliguet T, et al: 2020 ESC guidelines for the management of acute
coronary syndromes in patients presenting without persistent
ST-segment elevation. Eur Heart J. 42:1289–1367. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kaul P, Ezekowitz JA, Armstrong PW, Leung
BK, Savu A, Welsh RC, Quan H, Knudtson ML and McAlister FA:
Incidence of heart failure and mortality after acute coronary
syndromes. Am Heart J. 165:379–385.e2. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
McKnight AH, Katzenberger DR and Britnell
SR: Colchicine in acute coronary syndrome: A systematic review. Ann
Pharmacother. 55:187–197. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Smith JN, Negrelli JM, Manek MB, Hawes EM
and Viera AJ: Diagnosis and management of acute coronary syndrome:
An evidence-based update. J Am Board Fam Med. 28:283–293.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang L and Jin Y: Noncoding RNAs as
biomarkers for acute coronary syndrome. Biomed Res Int.
2020(3298696)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen H, Huang S, Guan F, Han S, Ye F, Li X
and You L: Targeting circulating lncRNA ENST00000538705.1 relieves
acute coronary syndrome via modulating ALOX15. Dis Markers.
2022(8208471)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Barbalata T, Niculescu LS, Stancu CS,
Pinet F and Sima AV: Elevated levels of circulating lncRNAs LIPCAR
and MALAT1 predict an unfavorable outcome in acute coronary
syndrome patients. Int J Mol Sci. 24(12076)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen L and Huang Y: High expression of
lncRNA PELATON serves as a risk factor for the incidence and
prognosis of acute coronary syndrome. Sci Rep.
12(8030)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao X, Chen L, Wu J, You J, Hong Q and Ye
F: Transcription factor KLF15 inhibits the proliferation and
migration of gastric cancer cells via regulating the
TFAP2A-AS1/NISCH axis. Biol Direct. 16(21)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhou B, Guo H and Tang J: Long non-coding
RNA TFAP2A-AS1 inhibits cell proliferation and invasion in breast
cancer via miR-933/SMAD2. Med Sci Monit. 25:1242–1253.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Y, Ma L, Zhang T, Li P, Xu J and
Wang Z: Long noncoding RNA TFAP2A-AS1 exerts promotive effects in
non-small cell lung cancer progression via controlling the
microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA. Oncol
Res. 29:129–139. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jie G, Peng S, Cui Z, He C, Feng X and
Yang K: Long non-coding RNA TFAP2A-AS1 plays an important role in
oral squamous cell carcinoma: Research includes bioinformatics
analysis and experiments. BMC Oral Health. 22(160)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Luo XY, Zhu XQ, Li Y, Wang XB, Yin W, Ge
YS and Ji WM: MicroRNA-150 restores endothelial cell function and
attenuates vascular remodeling by targeting PTX3 through the NF-κB
signaling pathway in mice with acute coronary syndrome. Cell Biol
Int. 42:1170–1181. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vedanthan R, Seligman B and Fuster V:
Global perspective on acute coronary syndrome: A burden on the
young and poor. Circ Res. 114:1959–1975. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Moran AE, Oliver JT, Mirzaie M,
Forouzanfar MH, Chilov M, Anderson L, Morrison JL, Khan A, Zhang N,
Haynes N, et al: Assessing the global burden of ischemic heart
disease: Part 1: Methods for a systematic review of the global
epidemiology of ischemic heart disease in 1990 and 2010. Glob
Heart. 7:315–329. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Forouzanfar MH, Moran AE, Flaxman AD, Roth
G, Mensah GA, Ezzati M, Naghavi M and Murray CJ: Assessing the
global burden of ischemic heart disease, part 2: Analytic methods
and estimates of the global epidemiology of ischemic heart disease
in 2010. Glob Heart. 7:331–342. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rogers WJ, Canto JG, Lambrew CT,
Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD and Every N:
Temporal trends in the treatment of over 1.5 million patients with
myocardial infarction in the US from 1990 through 1999: The
national registry of myocardial infarction 1, 2 and 3. J Am Coll
Cardiol. 36:2056–2063. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Thom T, Haase N, Rosamond W, Howard VJ,
Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S,
et al: Heart disease and stroke statistics-2006 update: A report
from the American heart association statistics committee and stroke
statistics subcommittee. Circulation. 113:e85–e151. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Menzin J, Wygant G, Hauch O, Jackel J and
Friedman M: One-year costs of ischemic heart disease among patients
with acute coronary syndromes: Findings from a multi-employer
claims database. Curr Med Res Opin. 24:461–468. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Libby P and Pasterkamp G: Requiem for the
‘vulnerable plaque’. Eur Heart J. 36:2984–2987. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bonetti PO, Lerman LO and Lerman A:
Endothelial dysfunction: A marker of atherosclerotic risk.
Arterioscler Thromb Vasc Biol. 23:168–175. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhu F, Wang Q, Guo C, Wang X, Cao X, Shi
Y, Gao F, Ma C and Zhang L: IL-17 induces apoptosis of vascular
endothelial cells: A potential mechanism for human acute coronary
syndrome. Clin Immunol. 141:152–160. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Stein RA: Endothelial dysfunction,
erectile dysfunction, and coronary heart disease: The
pathophysiologic and clinical linkage. Rev Urol. 5 (Suppl
7):S21–S27. 2003.PubMed/NCBI
|
|
27
|
Ling L, Zhao SP, Gao M, Zhou QC, Li YL and
Xia B: Vitamin C preserves endothelial function in patients with
coronary heart disease after a high-fat meal. Clin Cardiol.
25:219–224. 2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang YL and Zhao LY: AP-2 family of
transcription factors: Critical regulators of human development and
cancer. J Cancer Treat Diagn. 5:1–4. 2021.
|
|
29
|
Gestri G, Osborne RJ, Wyatt AW, Gerrelli
D, Gribble S, Stewart H, Fryer A, Bunyan DJ, Prescott K, Collin JR,
et al: Reduced TFAP2A function causes variable optic fissure
closure and retinal defects and sensitizes eye development to
mutations in other morphogenetic regulators. Hum Genet.
126:791–803. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang P, Hou Q and Yue Q:
MiR-204-5p/TFAP2A feedback loop positively regulates the
proliferation, migration, invasion and EMT process in cervical
cancer. Cancer Biomark. 28:381–390. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang HX, Yang G, Yang Y, Yan J, Tang XY
and Pan Q: TFAP2A is a novel regulator that modulates ferroptosis
in gallbladder carcinoma cells via the Nrf2 signalling axis. Eur
Rev Med Pharmacol Sci. 24:4745–4755. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xu H, Wang L and Jiang X: Silencing of
lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via
regulating miR-429/TFAP2A axis. Mol Cell Biochem. 476:1051–1061.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hutson MR and Kirby ML: Model systems for
the study of heart development and disease. Cardiac neural crest
and conotruncal malformations. Semin Cell Dev Biol. 18:101–110.
2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hammer S, Toenjes M, Lange M, Fischer JJ,
Dunkel I, Mebus S, Grimm CH, Hetzer R, Berger F and Sperling S:
Characterization of TBX20 in human hearts and its regulation by
TFAP2. J Cell Biochem. 104:1022–1033. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang K, Niu Y, Cui Z, Jin L, Peng S and
Dong Z: Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell
carcinoma cell growth and movement via competitively binding
miR-1297 and regulating TFAP2A expression. Mol Carcinog.
61:865–875. 2022.PubMed/NCBI View
Article : Google Scholar
|
